By When thousands of people are harmed by the same product, drug, or corporate decision, the legal system faces a fundamental challenge: how do you deliver justice efficiently without treating each victim as just a number? That is precisely the question driving the rapid expansion of mass tort litigation across the United States. As courts increasingly consolidate claims from hundreds or even thousands of plaintiffs into coordinated proceedings, the legal landscape is shifting in ways that affect everyday people, major corporations, and the attorneys who navigate these complex cases.
This article breaks down what is happening, why it matters, and what you need to know if you or someone you care about may be affected.
What Is Mass Tort Litigation and Why Is It Growing?
Mass tort litigation refers to civil legal proceedings in which a large number of plaintiffs bring individual claims against one or more defendants, typically alleging that a common product, substance, or action caused them harm. Unlike a class action lawsuit, where plaintiffs are grouped and represented collectively under a single verdict, mass tort cases preserve each plaintiff’s individual claim while coordinating the broader legal process to save time and resources.
The growth of these complex civil proceedings over the past decade is not accidental. Several converging forces have pushed these cases to the forefront of American civil justice:
- Widespread use of defective consumer products and pharmaceuticals
- More sophisticated plaintiff law firms are capable of managing large dockets
- Digital tools that help attorneys identify and connect with potential clients
- Growing public awareness of corporate accountability
- Court systems that have become more receptive to consolidation mechanisms
From opioid manufacturers to talcum powder producers, from social media companies to PFAS chemical polluters, the range of industries facing mass tort exposure has never been broader. Courts at both the state and federal levels have taken notice, developing structured tools to manage the resulting caseloads without sacrificing fairness.
How Courts Consolidate Mass Tort Cases
Multidistrict Litigation: The Federal Framework
The primary vehicle for consolidating mass tort litigation at the federal level is Multidistrict Litigation, commonly known as MDL. Governed by 28 U.S.C. § 1407, MDL allows the Judicial Panel on Multidistrict Litigation (JPML) to transfer civil cases involving common questions of fact to a single federal district court for coordinated pretrial proceedings.
When an MDL is created, a single judge called the transferee judge oversees the consolidated docket. This judge manages discovery, rules on dispositive motions, and works to resolve common factual and legal questions efficiently. Once pretrial proceedings are complete, cases can be remanded to their original courts for trial, or they may settle en masse.
The MDL system has become enormously influential. At any given time, MDL cases account for roughly 60 to 70 percent of all pending federal civil cases in the United States. The Camp Lejeune water contamination cases, the 3M Combat Arms Earplug litigation, and the ongoing JUUL e-cigarette proceedings are among the most prominent recent examples involving hundreds of thousands of individual claims.
Consolidated Proceedings at the State Level
State courts handle a significant portion of mass tort litigation through their own consolidation mechanisms. Procedures vary by jurisdiction, but many states have established specialized mass tort programs or Complex Litigation Centers designed to manage high-volume product liability and pharmaceutical cases.
New Jersey’s Complex Business Litigation Program and Pennsylvania’s Complex Litigation Center are widely regarded as two of the most developed frameworks in the country. These courts assign dedicated judges with experience in large-scale litigation, streamline discovery processes, and facilitate global settlements through active judicial management.
California, New York, and Illinois have similarly developed robust mechanisms for coordinating mass tort actions, particularly in the areas of toxic exposure, pharmaceutical injury, and consumer product defects.
Bellwether Trials: Testing the Waters
One of the most strategically important tools in consolidated mass tort proceedings is the bellwether trial. A bellwether case is a representative individual case selected from the broader consolidated docket and tried to verdict. The outcome gives both sides crucial information about how juries are likely to respond to the underlying claims, evidence, and defenses.
Bellwether verdicts do not bind other plaintiffs, but they carry enormous practical weight. A plaintiff’s verdict in a bellwether trial can signal significant exposure for the defendant and accelerate global settlement negotiations. Conversely, a defense verdict may prompt plaintiffs’ attorneys to reassess the viability of weaker claims.
The talcum powder litigation against Johnson & Johnson, which alleged links between asbestos-contaminated baby powder and ovarian cancer and mesothelioma, relied heavily on bellwether proceedings to shape the trajectory of eventual settlement discussions involving billions of dollars.
Recent Developments Reshaping the Landscape
The Rise of Mass Tort Bankruptcy
One of the most controversial and consequential recent developments in this area of civil law is the use of corporate bankruptcy to resolve mass liability. Dubbed the “Texas Two-Step” by critics, this strategy involves a company restructuring itself to segregate its tort liabilities into a newly created subsidiary, which then files for Chapter 11 bankruptcy protection.
The approach gained widespread attention when Johnson & Johnson attempted to use it to resolve tens of thousands of talcum powder claims. A subsidiary called LTL Management was created solely to hold the company’s talc liabilities and then immediately filed for bankruptcy. The Third Circuit Court of Appeals ultimately dismissed LTL’s second bankruptcy filing in 2024, ruling the company was not in financial distress and therefore could not use Chapter 11 for this purpose.
The decision sent a strong signal that courts will scrutinize attempts to use bankruptcy as a mass tort resolution vehicle when the parent company remains financially healthy. Legal observers widely expect continued litigation over the boundaries of this strategy in the coming years.
Social Media and Youth Mental Health Claims
One of the fastest-growing areas of mass tort litigation involves social media platforms and their alleged contribution to mental health crises among children and teenagers. Tens of thousands of plaintiffs, primarily the families of minors, have filed claims against Meta, TikTok, Snap, and other technology companies, alleging that addictive platform design caused anxiety, depression, eating disorders, and, in some cases, self-harm or suicide.
In October 2023, the JPML centralized these cases before Judge Yvonne Gonzalez Rogers in the Northern District of California, creating one of the most high-profile MDLs in recent memory. The litigation raises novel questions about Section 230 immunity, product liability standards for software platforms, and the duty of care owed by technology companies to young users.
The outcome of this MDL is expected to have far-reaching implications not only for the companies named as defendants but for the regulatory environment surrounding social media more broadly.
PFAS and Environmental Mass Torts
Per- and polyfluoroalkyl substances, widely known as PFAS or “forever chemicals,” have become one of the most active areas of mass tort litigation in recent years. These synthetic chemicals are found in everything from firefighting foam to nonstick cookware, and studies have linked long-term PFAS exposure to various cancers, thyroid disease, and immune system dysfunction.
3M Company agreed to a landmark settlement of up to $10.3 billion in June 2023 to resolve claims brought by public water systems across the country contaminated with PFAS from 3M’s Aqueous Film Forming Foam. DuPont and its spinoffs reached a separate settlement of approximately $1.185 billion with water utilities. Individual personal injury claims related to PFAS exposure remain actively consolidated in federal court, with the litigation expected to expand significantly in the coming years as more communities identify contamination.
What Plaintiffs Experience in a Mass Tort Case
Understanding what it feels like to be a plaintiff in mass tort litigation helps demystify a process that can otherwise seem abstract.
Most people who join a mass tort proceeding do not go to trial individually. Their cases are filed, enrolled in the consolidated proceeding, and managed through a discovery and settlement process that can take years. They typically work with a law firm that specializes in the relevant litigation, communicating periodically about case developments, submitting medical records and other documentation, and eventually receiving an offer as part of a global settlement.
This process can be frustrating for plaintiffs who want their day in court, but it also means that many people who could not afford years of individual litigation are able to pursue compensation they otherwise might never see. The trade-off between efficiency and individual attention is one of the defining tensions of the mass tort system.
Attorneys’ fees in mass tort cases are typically contingency-based, meaning plaintiffs pay nothing upfront and lawyers collect a percentage, commonly between 30 and 40 percent only if a recovery is obtained. Courts in MDL proceedings often establish common benefit fee arrangements to compensate attorneys who do work that benefits all plaintiffs in the litigation, not just their own clients.
The Defense Perspective: Navigating Mass Tort Exposure
For corporations, mass tort litigation represents one of the most significant legal and financial risks in modern business. A single product or chemical linked to widespread harm can generate tens of thousands of claims and liability exposures running into the billions of dollars.
Companies facing mass tort exposure typically deploy several strategies. Early in litigation, they challenge the science underlying plaintiffs’ claims, filing Daubert motions to exclude expert testimony that does not meet the standards for admissibility under federal evidentiary rules. They also aggressively pursue case management orders that limit discovery costs and protect confidential business information.
In cases involving truly enormous numbers of claims, defendants often seek global resolution through negotiated settlement programs, sometimes called settlement matrices, that assign compensation values to different categories of injury based on diagnosis, severity, and other factors. These structured programs allow companies to achieve finality, a predictable end to their liability, while providing compensation to injured plaintiffs more quickly than individual trials ever could.
How Settlements Are Structured in Large-Scale Cases
One of the most consequential and least understood aspects of mass tort litigation is how compensation actually reaches injured people. When a defendant agrees to resolve a large docket, the parties typically negotiate a global settlement, a total fund of money set aside to compensate all qualifying claimants. How that fund is divided is governed by a settlement matrix or allocation protocol developed by the parties and overseen, in MDL proceedings, by the court-appointed Special Master.
The Role of the Special Master
A Special Master is a neutral expert often a retired judge or experienced attorney appointed by the court to assist with complex aspects of case management. In the settlement context, Special Masters review individual claims, evaluate documentation, and recommend compensation amounts based on established criteria. This structure is essential in mass tort litigation because the sheer volume of claims makes individualized judicial review of every case impractical.
Special Masters have played central roles in some of the largest settlements in American legal history. The September 11th Victim Compensation Fund, the NFL Concussion Settlement, and the Purdue Pharma opioid bankruptcy proceedings all relied heavily on Special Masters to administer claim evaluation and payment processes involving thousands or tens of thousands of claimants.
Lien Resolution: The Hidden Complexity
Before a settlement check reaches an injured plaintiff, a critical and often frustrating process called lien resolution must be completed. When Medicare, Medicaid, or private health insurers have paid for a plaintiff’s medical treatment related to their injury, federal and state law require that those payments be reimbursed from any personal injury recovery. Resolving these liens, identifying the amounts owed, negotiating reductions, and obtaining lien holders’ consent can add months to the post-settlement timeline.
In mass tort litigation involving pharmaceutical injuries or toxic exposures, lien resolution is a significant undertaking managed by specialized lien resolution firms working alongside plaintiffs’ attorneys. Understanding this process helps claimants set realistic expectations about when and how much of their settlement they will actually receive.
Key Trends to Watch in the Coming Years
The trajectory of mass tort litigation points toward several developments worth monitoring:
Litigation Funding’s Expanding Role
Third-party litigation financing, in which investment firms provide capital to plaintiffs’ law firms in exchange for a share of eventual recoveries, has become a significant force in these large-scale injury cases. Critics argue it creates conflicts of interest and inflates settlement demands. Supporters contend it democratizes access to justice by allowing smaller firms to compete against well-funded corporate defendants. Regulatory scrutiny of litigation funding is increasing at both the state and federal levels.
Artificial Intelligence and Case Management
Emerging artificial intelligence tools are beginning to transform how mass tort litigation is managed. Platforms capable of processing thousands of medical records, identifying case values, and flagging inconsistencies are being adopted by plaintiff and defense firms alike. Courts are also exploring AI-assisted tools for docket management in large MDL proceedings.
International Expansion
While mass tort litigation has traditionally been a predominantly American phenomenon, other common law jurisdictions particularly the United Kingdom, Australia, and Canada are developing their own mechanisms for handling large-scale tort claims. Cross-border mass tort actions involving multinational defendants are becoming more common, adding layers of complexity to an already sophisticated practice area.
Key Takeaways
- Mass tort litigation allows many individuals harmed by the same cause to pursue compensation through coordinated proceedings while keeping individual claims intact — unlike class actions, which produce a single collective outcome.
- Federal Multidistrict Litigation (MDL) consolidates cases involving common facts before a single judge and currently accounts for the majority of all pending federal civil cases in the United States.
- Bellwether trials serve as test cases that reveal likely jury reactions and often accelerate global settlement negotiations without binding every plaintiff to the result.
- Recent high-profile expansions include social media and youth mental health claims, PFAS environmental contamination, and continued pharmaceutical litigation each pushing the boundaries of how courts manage massive dockets.
- The “Texas Two-Step” bankruptcy strategy, used by some companies to contain mass tort liability, has faced significant judicial pushback and remains a contested and evolving area of law.
- Plaintiffs in mass tort litigation typically work through contingency-fee attorneys, submit documentation during discovery, and receive compensation through structured settlement programs rather than individual trials.
- Litigation funding, artificial intelligence tools, and international expansion are reshaping the mass tort landscape in ways that will influence how courts, corporations, and claimants approach large-scale harm for years to come.
Conclusion
The expansion of mass tort litigation reflects a broader societal reckoning with the harm caused by defective products, dangerous chemicals, and irresponsible corporate practices. As courts develop increasingly sophisticated tools for consolidating and managing these cases, the system is becoming simultaneously more efficient and more influential capable of delivering compensation to thousands of injured people while also sending powerful signals to industries about the cost of cutting corners on safety.
For anyone affected by a product, drug, or environmental exposure linked to widespread harm, understanding how this system works is the first step toward knowing your rights. For legal professionals, policymakers, and business leaders, the trajectory of mass tort litigation offers a window into the future of corporate accountability in America. The cases being filed and consolidated today will shape that future in ways we are only beginning to understand.